umeclidinium and vilanterol ellipta
Generic: umeclidinium bromide and vilanterol trifenatate
Labeler: prasco laboratoriesDrug Facts
Product Profile
Brand Name
umeclidinium and vilanterol ellipta
Generic Name
umeclidinium bromide and vilanterol trifenatate
Labeler
prasco laboratories
Dosage Form
POWDER
Routes
Active Ingredients
umeclidinium bromide 62.5 ug/1, vilanterol trifenatate 25 ug/1
Manufacturer
Identifiers & Regulatory
Product NDC
66993-134
Product ID
66993-134_bffa73f4-99ab-49a2-b585-0982dd611110
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA203975
Listing Expiration
2026-12-31
Marketing Start
2025-04-11
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
66993134
Hyphenated Format
66993-134
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
umeclidinium and vilanterol ellipta (source: ndc)
Generic Name
umeclidinium bromide and vilanterol trifenatate (source: ndc)
Application Number
NDA203975 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 62.5 ug/1
- 25 ug/1
Packaging
- 1 TRAY in 1 CARTON (66993-134-97) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "bffa73f4-99ab-49a2-b585-0982dd611110", "openfda": {"unii": ["7AN603V4JV", "40AHO2C6DG"], "rxcui": ["1487527"], "spl_set_id": ["6de414b1-f707-4b98-9e4b-742032ec90af"], "manufacturer_name": ["Prasco Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TRAY in 1 CARTON (66993-134-97) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER", "package_ndc": "66993-134-97", "marketing_start_date": "20250411"}], "brand_name": "Umeclidinium and Vilanterol Ellipta", "product_id": "66993-134_bffa73f4-99ab-49a2-b585-0982dd611110", "dosage_form": "POWDER", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "66993-134", "generic_name": "umeclidinium bromide and vilanterol trifenatate", "labeler_name": "Prasco Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Umeclidinium and Vilanterol Ellipta", "active_ingredients": [{"name": "UMECLIDINIUM BROMIDE", "strength": "62.5 ug/1"}, {"name": "VILANTEROL TRIFENATATE", "strength": "25 ug/1"}], "application_number": "NDA203975", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20250411", "listing_expiration_date": "20261231"}